E-LIB Suche - Ergebnisse für: Lockhart, A. Craig

1

Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine k..:

Pedersen, Katrina S. ; Grierson, Patrick M. ; Picus, Joel...
Investigational New Drugs. 39 (2021) 5 - p. 1298-1305 , 2021

Link: https://doi.org/10.1007/..

2

Large-scale analysis of KMT2 mutations defines a distinctiv..:

Wang, Jingyuan ; Xiu, Joanne ; Baca, Yasmine...
Oncogene. 40 (2021) 30 - p. 4894-4905 , 2021

Link: https://doi.org/10.1038/..

3

A single-institution phase I feasibility study of dose-esca..:

Vlacich, Gregory ; Ballard, Andrew ; Badiyan, Shahed N....
Clinical and Translational Radiation Oncology. 30 (2021) - p. 19-25 , 2021

Link: https://doi.org/10.1016/..

4

Phase 1 Study to Evaluate the Effect of the Investigational..:

Patel, Chirag ; Goel, Sanjay ; Patel, Manish R....
Clinical Pharmacology in Drug Development. 9 (2020) 7 - p. 876-888 , 2020

Link: https://doi.org/10.1002/..

5

A phase I trial of temsirolimus and erlotinib in patients w..:

Park, Haeseong ; Williams, Kerry ; Trikalinos, Nikolaos A....
Cancer Chemotherapy and Pharmacology. 87 (2020) 3 - p. 337-347 , 2020

Link: https://doi.org/10.1007/..

6

Role of Immunotherapy in Advanced Gastroesophageal Cancer:

Terrero, Gretel ; Lockhart, A. Craig
Current Oncology Reports. 22 (2020) 11 - p. , 2020

Link: https://doi.org/10.1007/..

7

A phase 1b study evaluating the safety and pharmacokinetics..:

Weekes, Colin ; Lockhart, A. Craig ; Lee, James J....
International Journal of Cancer. 145 (2019) 9 - p. 2450-2458 , 2019

Link: https://doi.org/10.1002/..

8

Effect of CYP3A inhibitors on the pharmacokinetics of pevon..:

Faessel, Hélène ; Nemunaitis, John ; Bauer, Todd M....
British Journal of Clinical Pharmacology. 85 (2019) 7 - p. 1464-1473 , 2019

Link: https://doi.org/10.1111/..

9

Folate Receptor α-Targeted 89Zr-M9346A Immuno-PET for Image..:

Heo, Gyu Seong ; Detering, Lisa ; Luehmann, Hannah P....
Molecular Pharmaceutics. 16 (2019) 9 - p. 3996-4006 , 2019

Link: https://doi.org/10.1021/..

10

Pharmacokinetics of the Investigational Aurora A Kinase Inh..:

Zhou, Xiaofei ; Lockhart, A. Craig ; Fu, Siqing...
The Journal of Clinical Pharmacology. 59 (2019) 9 - p. 1204-1215 , 2019

Link: https://doi.org/10.1002/..

11

Final results of a phase I dose-escalation, dose-expansion ..:

Huang, Jiayi ; Campian, Jian L. ; Gujar, Amit D....
Journal of Neuro-Oncology. 138 (2018) 1 - p. 105-111 , 2018

Link: https://doi.org/10.1007/..

12

Phase Ib study of pevonedistat, a NEDD8-activating enzyme i..:

Lockhart, A Craig ; Bauer, Todd M. ; Aggarwal, Charu...
Investigational New Drugs. 37 (2018) 1 - p. 87-97 , 2018

Link: https://doi.org/10.1007/..

13

Effects of rifampin, itraconazole and esomeprazole on the p..:

Zhou, Xiaofei ; Pant, Shubham ; Nemunaitis, John...
Investigational New Drugs. 36 (2017) 2 - p. 248-258 , 2017

Link: https://doi.org/10.1007/..

14

Academic Cancer Center Phase I Program Development:

Frankel, Arthur E. ; Flaherty, Keith T. ; Weiner, George J....
The Oncologist. 22 (2017) 4 - p. 369-374 , 2017

Link: https://doi.org/10.1634/..

15

Treatment utilization and outcomes in elderly patients with..:

Vlacich, Gregory ; Samson, Pamela P. ; Perkins, Stephanie M....
Cancer Medicine. 6 (2017) 12 - p. 2886-2896 , 2017

Link: https://doi.org/10.1002/..